These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8440808)

  • 1. Do reversed depressive symptoms occur together as a syndrome?
    Spoov J; Suominen JY; Lahdelma RL; Katila H; Kymäläinen O; Isometsä E; Liukko H; Auvinen J
    J Affect Disord; 1993 Feb; 27(2):131-4. PubMed ID: 8440808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute therapy of depression.
    Bech P
    J Clin Psychiatry; 1993 Aug; 54 Suppl():18-27; discussion 28. PubMed ID: 8253702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression.
    Paykel ES
    Acta Psychiatr Scand Suppl; 1995; 386():22-7. PubMed ID: 7717091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moclobemide. An update of its pharmacological properties and therapeutic use.
    Fulton B; Benfield P
    Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moclobemide--placebo-controlled trials.
    Silverstone T
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M; Guelfi JD
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
    Versiani M
    J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of moclobemide in endogenous depression: a survey of recent data.
    Woggon B
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):137-9. PubMed ID: 8468434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients.
    Monti JM
    Br J Psychiatry Suppl; 1989 Oct; (6):61-5. PubMed ID: 2619974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients.
    Nair NP; Ahmed SK; Kin NM; West TE
    Acta Psychiatr Scand Suppl; 1995; 386():28-35. PubMed ID: 7717092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
    Lecrubier Y; Guelfi JD
    Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
    J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
    König F; Wolfersdorf M
    Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical depression: Clinical perspectives].
    Lutz M; Morali A; Lang JP
    Encephale; 2013 Sep; 39(4):258-64. PubMed ID: 23541919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M; Nardi AE; Figueira IL; Stabl M
    Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M; Biziére K; Schmid-Burgk W; Amrein R
    J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
    Jouvent R; Le Houezec J; Payan C; Mikkelsen H; Fermanian J; Millet V; Dufour H
    Psychiatry Res; 1998 Jul; 79(3):267-75. PubMed ID: 9704873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The symptoms, neurobiology, and current pharmacological treatment of depression.
    To SE; Zepf RA; Woods AG
    J Neurosci Nurs; 2005 Apr; 37(2):102-7. PubMed ID: 15902953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.